Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Inhibitors of c-jun-N-Terminal Kinase (JNK)

Author(s): Philip LoGrasso and Theodore Kamenecka

Volume 8, Issue 8, 2008

Page: [755 - 766] Pages: 12

DOI: 10.2174/138955708784912120

Price: $65

Abstract

Inhibitors of c-jun-N-Terminal Kinase (JNK) have many potential therapeutic indications ranging from neurodegenerative disease, to metabolic disorders, inflammation, cardiovascular disease, and cancer. This overview will highlight biological inhibitors such as JNK-interacting protein (JIP) as well as small molecule inhibitors from various structural classes including, aminopyrimidines and indazoles.

Keywords: c-jun-N-Terminal Kinase (JNK), mitogen activated protein (MAP), benzothiazole pyrimidines, benzothien-2-yl amides, indazoles, aminopyrimidines, aminopyridines, quinolines


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy